1084P PLATForM: Descriptive analysis from a randomised, phase II study of novel spartalizumab combinations in previously treated unresectable/metastatic melanoma

Autor: Robert, C., Schadendorf, D., Long, G.V., Ascierto, P., Intagliata, S., Meier, F., van der Veldt, A.A.M., Ribas, A., Weber, J.S., Stenson, L., Solovieff, N., Louveau, A-L., Boran, A.D., Grob, J.J., Dummer, R.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S898-S898
Databáze: ScienceDirect